Intestinal Microbiota
14
1
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
87.5%
+1.0% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Oral and Gut Microbiota in Individuals With Serrated Polyposis Syndrome.
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
Research on the Role of Probiotics in Human Intestinal Health
Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection
Dietary Intervention to Reduce Metabolic Endotoxemia
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
The Diversity of Intestinal Microbiota in Patients With Different Sedative-hypnotics Undergoing Mechanical Ventilation
Human Microbiota and Liver Transplant
Effect of the Use of Symbiotics in Patients With Colon Cancer
NUTRIPROTECT-Children Nutrition as a Protective or Health-risk Factor
Effects of Consumption of Nut Components on Cognitive Function, Intestinal Microbial Communities and Markers of Health
Medically-Graded Honey Supplementation Formula To Preterm Infants
Effect of Diet on Intestinal Microbiota and Obesity Markers in Adults